Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0047 | 0.0351 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0625 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0026 | 0 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0625 | 1 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0625 | 1 | 0.5 |
Schistosoma mansoni | ephrin receptor | 0.0029 | 0.005 | 0.0014 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.005 | 0.0406 | 0.0372 |
Brugia malayi | Hemopexin family protein | 0.003 | 0.007 | 0.007 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0625 | 1 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0625 | 1 | 1 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.0051 | 0.0421 | 0.0421 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0077 | 0.0849 | 0.0816 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0028 | 0.0036 | 0.0036 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0625 | 1 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.0026 | 0 | 0.5 |
Onchocerca volvulus | 0.003 | 0.007 | 0.1093 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0625 | 1 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0047 | 0.0351 | 1 |
Schistosoma mansoni | hypothetical protein | 0.003 | 0.007 | 0.0035 |
Loa Loa (eye worm) | matrixin family protein | 0.0047 | 0.0351 | 0.0351 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0625 | 1 | 0.5 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0077 | 0.0849 | 0.0816 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0625 | 1 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0625 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0625 | 1 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0625 | 1 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0625 | 1 | 0.5 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0029 | 0.005 | 0.0014 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0625 | 1 | 1 |
Brugia malayi | Matrixin family protein | 0.0051 | 0.0421 | 0.0421 |
Brugia malayi | protein unc-22 | 0.0028 | 0.0036 | 0.0036 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0625 | 1 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0625 | 1 | 0.5 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0029 | 0.005 | 0.0014 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0028 | 0.0036 | 0.0036 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0028 | 0.0036 | 0.0036 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0625 | 1 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0625 | 1 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0625 | 1 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0625 | 1 | 1 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0028 | 0.0036 | 0.0036 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of pig kidney microsomal APN using L-Leu-p-nitroanilide as substrate preincubated for 30 mins by UV-vis spectrophotometry | ChEMBL. | 24247003 | |
IC50 (binding) | = 0.325 uM | Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry | ChEMBL. | 24247003 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.